Pseudotropyl halogeno-benzoates and their use in migraine treatment
US4486441A · kind A · utility
16Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 1982 |
| Grant date | Dec 4, 1984 |
| Priority date | — |
| Expiry date | Dec 8, 2002 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Migraine is treated with a novel pseudotropyl benzoate derivative of the following general Formula I: ##STR1## wherein: R.sub.1 represents halogen, preferably chlorine; PA1 R.sub.2 represents hydrogen or halogen, preferably chlorine; and PA1 R.sub.3 represents hydrogen or halogen, preferably chlorine, provided that R.sub.3 is hydrogen when R.sub.2 is hydrogen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.